Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04869826
Other study ID # RS#: 2021-3003; R#: 101246
Secondary ID STP-PW2-002
Status Recruiting
Phase
First received
Last updated
Start date June 15, 2021
Est. completion date December 31, 2023

Study information

Verified date February 2023
Source Cardiovascular Research New Brunswick
Contact Christie Aguiar, PhD
Phone 506-977-2712
Email christie.aguiar@CloudDX.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to calibrate the blood pressure measurements of the Pulsewave Health Monitor (PAD-2A) device to be within 5±8 mmHg of the average of the dual-observer measurements via an aneroid sphygmomanometer (reference device), as per the methodology described in the ISO 81060-2: AMD_2020 protocol.


Description:

The plan for this study is to calibrate the blood pressure measurements of the PAD-2A device with the dual-observer blood pressure measurements via an aneroid sphygmomanometer (reference device), as per the ISO 81060-2: AMD_2020 protocol. The data will be collected and analyzed in order to calibrate the PAD-2A device blood pressure measurements to be within 5±8 mmHg of the average of the dual-observer auscultatory blood pressure measurements by adjusting the device algorithm.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Adults = 19 years of age (minimum 30% male/female) - Wrist circumference between 13.5 cm. - 23 cm. (5.3 in. - 9.1 in.): Specifically for this test device, the wrist size of the consented participants will be distributed accordingly for a Gaussian distribution: Lowest Octile: = 13.5cm to < 14.7cm Lower Quarter: = 13.5cm to < 15.9cm Lower-Middle Quarter: = 15.9cm to < 18.3cm Upper-Middle Quarter: = 18.3cm to < 20.7cm Upper Quarter: = 20.7cm to = 23.0cm Highest Octile: = 21.9cm to = 23.0cm ? Willing to volunteer to participate and to sign the study specific informed consent form Exclusion Criteria: - Wrist circumference less than 13.5 cm. (5.3 in.) or greater than 23 cm. (9.1 in) - Hand or body tremors - Irregular heart rhythm (bigeminy, trigeminy, isolated ventricular premature beat (VPB), atrial fibrillation) - Korotkoff sound K5 not audible - Pregnant - A musculoskeletal disorder that prevents a non-invasive device to be inflated/deflated on the arm - Unwilling to volunteer to participate and to sign the study specific informed consent form

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Pulsewave Health Monitor (PAD-2A) Device
This is an observational, comparison study of blood pressure measurements. The objective of this study is to calibrate the blood pressure measurements of the Pulsewave Health Monitor (PAD-2A) device to be within 5±8 mmHg of the average of the dual-observer auscultatory blood pressure measurements via an aneroid sphygmomanometer (reference device), as per the ISO 81060-2: AMD_2020 universal protocol.

Locations

Country Name City State
Canada Horizon Health Network Saint John

Sponsors (5)

Lead Sponsor Collaborator
Cardiovascular Research New Brunswick Cloud DX Inc., Dalhousie University, Horizon Health Network, New Brunswick Health Research Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Systolic Pressure Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff blood pressure device (mmHg) From the start of cuff inflation to the end of cuff deflation (approximately 60 seconds)
Primary Systolic Pressure Simultaneous auscultatory blood pressure measurements by 2 trained observers From the start of manual inflation of the upper arm blood pressure cuff to the end of (manual) deflation of the upper arm blood pressure cuff (approximately 30-60 seconds)
Primary Diastolic Pressure Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff blood pressure device (mmHg) From the start of cuff inflation to the end of cuff deflation (approximately 60 seconds)
Primary Diastolic Pressure Simultaneous auscultatory blood pressure measurements by 2 trained observers From the start of manual inflation of the upper arm blood pressure cuff to the end of (manual) deflation of the upper arm blood pressure cuff (approximately 30-60 seconds)
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A